Literature DB >> 1425882

Lack of pharmacokinetic interaction between moxonidine and hydrochlorothiazide.

H J Weimann, G Pabst, W Weber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425882     DOI: 10.1007/bf01740675

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  7 in total

1.  [Long-term experiences with moxonidine, a new antihypertensive agent].

Authors:  W Schwarz; J Kandziora
Journal:  Fortschr Med       Date:  1990-11-10

Review 2.  Review of methods and criteria for the evaluation of bioequivalence studies.

Authors:  G Pabst; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers.

Authors:  D Trenk; F Wagner; E Jähnchen; V Plänitz
Journal:  J Clin Pharmacol       Date:  1987-12       Impact factor: 3.126

4.  The influence of renal function on clinical pharmacokinetics of moxonidine.

Authors:  W Kirch; H J Hutt; V Plänitz
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

5.  Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine.

Authors:  B I Armah
Journal:  Arzneimittelforschung       Date:  1988-10

6.  Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients.

Authors:  W Kirch; H J Hutt; V Plänitz
Journal:  J Clin Pharmacol       Date:  1990-12       Impact factor: 3.126

7.  Absolute bioavailability of moxonidine.

Authors:  R Theodor; H J Weimann; W Weber; K Michaelis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

  7 in total
  1 in total

Review 1.  Safety and tolerability of moxonidine in the treatment of hypertension.

Authors:  M Schachter; J Luszick; B Jäger; C Verboom; E Söhlke
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.